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Comparison of the antigenic targets involved in antibody-mediated
membranous glomerulonephritis in the mouse and the rat. K. J. M.
Assmann, W. P. J. Lange, M. M. Tan gelder, and R. A. P. Koene.
Department of Pathology and Department o.f Medicine, Division of
Nephrology, Sint Radboudziekenhuis, University of Nzjmegen, The
Netherlands. Membranous glomerulonephritis in the mouse can be
induced by a single injection of an antiserum against homologous,
pronase-digested, renal tubular antigens (TAPron). In this antiserum an
antibody population was present directed against an antigen located on
the glomerular epithelium. We have now compared the rat antigen
responsible for the binding of antibodies in the passive Heymann
nephritis (PHN, Heymann antigen) with the glomerular antigen in the
mouse. Heterologous antisera against mouse TAPron. rat TAPron, and
mouse Fx1A strongly stained the brush borders of proximal tubular
epithelia of normal mouse and rat kidneys in the indirect immunofluo-
rescence (hF). Staining of the glomeruli, however, was different. Anti-
mouse FxIA did not fix to the mouse glomerulus, while giving a fine
granular pattern along the capillary wall of the rat. Anti-mouse and rat
TAPron reacted strongly with the visceral epithelia of the mouse in a
homogeneous pattern, while a faint granular staining was seen in the rat
glomerulus against a homogeneous background. After injection in rats,
a classic PHN could be induced by all these sera. Immunoglobulins
eluted from glomeruli of rats, previously injected with anti-mouse
TAPron, bound strongly to the tubular BB of mouse and rat in the hF.
The mouse glomerulus was completely negative, but the rat glomerulus
showed a fine granular staining along the capillary wall. Discrete
localization in coated pits, multivesicular bodies, and endoplasmic
reticulum of the visceral epithelia was seen in immuno-electronmicros-
copy. In vivo binding of the eluate was only demonstrable in the rat
glomerulus, where small subepithelial deposits were present 5 days
after intravenous injection. The results show that antisera against
pronase-digested, renal tubular antigens contain a population of anti-
bodies directed against the Heymann antigen in the rat glomerular
visceral epithelia and crossreacting with an antigen in the BB of both
mouse and rat. Another population fixes to an antigen on the visceral
epithelial cell membranes of the mouse and to a lesser degree of the rat,
leading in this last species to a mixed pattern of discrete granules
against homogeneous background. This homogeneously distributed
antigen differs from the Heymann antigen and is probably exposed by
the pronase digestion of the renal tubular fraction. Despite the absence
of the Heymann antigen in the mouse glomerulus, these animals
develop a typical membranous glomerulonephritis after injection of the
appropriate antibodies.
Anti-T-cell specificity and localization of heterologous nephritogenic
antibodies in the rat. W. M. Bagchus, J. T. W. M. Vos, and W. W.
Bakker. Department of Pathology, University of Groningen, Gronin-
gen, The Netherlands. Injection of rabbit antibodies directed to rat
tubular brushborder antigens (FxlA) into rats gives rise to in situ
immune complex formation along the glomerular capillary walls. The
resulting heterologous immune complex glomerulopathy (HIC) is char-
acterized by subepithelial immune aggregates along the glomerular
basement membrane (GBM). It has been shown previously that anti-
Fx1A after thorough absorption with rat tissue antigens shows anti-T-
cell activity, whereas eluates of kidney tissue from rats with HIC show
also anti-T-cell binding as detected by indirect membrane IF on fresh
rat thymocyte suspensions. In addition, conventionally raised rabbit
anti-thymocyte serum (ATS), after thorough absorption, was also able
to bind with subepithelial structures following perfusion ex vivo in the
bloodfree rat kidney. The question was raised, whether anti-T-cell
activity per se might play a role in the nephritogenicity of anti-FxIA. To
answer this question we have removed anti-T activity from anti-Fx1A
by absorption with thymocyte membrane extracts mixed with rat heart
tissue extract (RHE), for 24 hr at 4°C (250 mg/l00 .iJ lgG), whereas
bovine heart extract (BHE) was used as control immunoabsorbent.
After absorption with either RHE or BHE the absorbent was spun
down for 60 mm (x lOO,000g), the supernatants were concentrated
(Amicon 25) and the antibrushbordcr titers were adjusted until equal
titers were obtained. Staining for T cells using membrane IF on rat
thymocytes showed negative staining with RHE absorbed anti-FxIA
(antibrushborder titer 1/128) and positive staining with control anti-
Fx1A. Ex vivo perfusion of RHE absorbed anti-FxIA into the blood-
free rat kidney, in contrast to BHE absorbed anti-FxIA, did not show
localization of the antibody along the GBM as detected by IF of
sections of perfused kidneys. Since in vitro incubation of kidney
sections with RHE absorbed anti-FxIA showed no binding of the
antibodies along the GBM in contrast to BHE absorbed anti-FxlA,
using IEM with peroxidase conjugated antibodies, it is concluded from
these data that the presence of anti-T activity in heterologous anti-FxlA
may play a role in the binding of these antibodies to the GBM.
B-cell activity in vivo and in vitro in systemic lupus erythematosus
(SLE). C. G. M. Kallenberg, P. C. Limburg, and T. H. The. Depart-
ment of Clinical Immunology, University Hospital, Groningen, The
Netherlands. B-lymphocyte studies, in vivo and in vitro, were per-
formed in 28 SLE patients in various stages of disease activity. After
immunization with the T-cell dependent primary test-antigen hemocya-
nm, a decreased antigen-specific humoral immune response was ob-
served for all three Ig classes, irrespective of disease activity or the use
of corticosteroids. However, levels of antibodies against (recall) viral
antigens were increased during active disease; changes in titer more
than twofold were observed without clinical evidence of infection.
Also, levels of antibodies against nuclear antigens were increased
during active disease. The in vitro spontaneous production of IgG, but
not of 1gM, as determined in the supernatant of 8-day cultures by
ELISA, was highly increased in patients with active disease (negatively
correlated with levels of complement C3, r 0,74). Kinetics of the
spontaneous in vitro IgG synthesis by unseparated cells and non-T cells
demonstrated that activation of B-cells did not occur in vitro (as a result
of a defective autologous mixed lymphocyte reaction), but was already
present in vivo. Pokeweed mitogen (PWM)-iriduced synthesis of IgG
and especially of 1gM was decreased in all patients. In patients with
active disease, PWM-induced IgG synthesis was even lower than the
spontaneous synthesis. Depletion and reconstitution of T-cells demon-
strated that this phenomenon resulted from PWM-induced activation of
T-cells with suppressive effect on the lgG synthesis by B-cells. Allo-
genic co-culture studies, also, did not reveal gross defects in T-
suppressor cell activity in (active) SLE. In general, the distribution of
T-cell subsets (OKT3, Leu3a, and OKT8 positive cells) did not differ
from control subjects, irrespective of disease activity. It is concluded
that the primary humoral immune response is decreased in SLE,
whereas a (restricted) polyclonally activated B-cell system appears to
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be present. The results of studies on T-cell function and subset
distribution do not support the primary role suggested for the T-cell in
the state of hyperactivity of the B-cell.
The acute antihypertensive effect of nifedipine, before and during
alpha-i blockade with prazosin. H. E. Sluiter, F. T. M. Huysmans, T. A.
Thien, and R. A. P. Koene. Departments of Nephrology and General
Internal Medicine, St. Radboud University Hospital, Nijmegen, The
Netherlands. It has been suggested that the calcium-antagonist nifedi-
pine exerts part of its vasodilating action by interference with postsyn-
aptic alpha-2-mediated vasoconstriction. A compensatory rise in sym-
pathetic nerve activity after nifedipine might partially antagonize this
effect by an alpha-I-receptor mediated vasoconstriction which may be
accessible to blockade by prazosin. Therefore, we investigated the
effects of nifedipine, 20 mg sublingually, on BP and heart rate (Arterio-
sonde) before and 2 hr after pretreatment with prazosin, 2 mg orally, in
eight patients with untreated hypertension (BP 175/1 16 74 mm Hg;
mean sEM). Blood samples were taken at 0 and 60 mm after
nifedipine. After nifedipine alone, there was a decrease of mean arterial
pressure (MAP) of 8.5 2.4% at 60 mm and of 4.5 3.0% at 90 mm.
Heart rates and plasma catecholamines rose significantly. PRA and
aldosterone levels did not change significantly. Twelve percent rises in
hemoglobin, hematocrit, albumin, and protein concentrations suggested
a decrease of plasma volume, probably caused by a diuretic effect of the
drug. Two hours after prazosin there were no significant changes in
MAP and heart rate. Nifedipine, given after prazosin, caused a signifi-
cantly greater decrease of MAP (16.7 2.7 and 18.4 2.1% at 60 and
90 mm, respectively), whereas changes in hormonal parameters and
heart rates were comparable to those observed after nifedipine alone.
However, the effect on plasma volume seemed less pronounced, with
only a 5% increase in hemoglobin, hematocrit, albumin, and protein
concentrations. Our data suggest that the acute antihypertensive effect
of nifedipine is enhanced by prazosin. Preliminary experience points to
adequate long-term BP control with a combination of low doses of both
drugs.
Hepatitis Be antigen mediated membranous glomerulonephritis? J.
Wolters, H. Houthoff, P. van Breda Vriesman, T. Felikamp-Vroom, W.
Grave, J. Mooy, T. pd. Wiel, and E. Zeppenfeldt. Regionale Nierwerk-
groep Z. Limburg, Pathologie Anatomic RU Groningen, Pathologic
Anatomic Slotervaartziekenhuis Amsterdam, Amsterdam, The Nether-
lands. A 20-year-old man developed transiently gross hematuria and the
nephrotic syndrome; he had a hepatitis B infection (HbsAg +, Hbe +,
anti-Hbc +) serologically and a mild chronic persisting hepatitis
(HbsAg +) detected on his liver biopsy specimen when he was
admitted. The renal biopsy specimen revealed a membranous glomeru-
lopathy with IgG, C3, and Hbe antigen deposited along the capillary
walls. HbsAg and 1gM were seen mesangially only. Fluid phase Clq,
solid phase Clq, and solid phase anti-C3 assays were normal. The
glomerular Hbe deposition was specific immunohistochemically and
clinically. Seventeen other patients with membranous nephropathy—
and no known hepatitis B infection—failed to show glomerular Hbe
antigen. Treatment with vidarabine (I year after the onset of nephrotic
syndrome) switched the patient from Hbe Ag positive to anti-Hbe Ag
positive. Four months after being switched to the (healthy) carrier state
serologically the nephrotic syndrome had not remitted, suggesting that
Hbe antigen Hbe antibody complexes may not mediate the nephrotic
syndrome or, alternatively, that after cutting off the antigen supply the
glomerular immune complex deposits require many months for
dissolution.
Factors contributing to the development of glomerular sclerosis in rats.
J. Grond, J. J. B. Beukers, M. S. Schilthuis, H. van Goor, J. J.
Weening, and]. D. Elema. Departments of Pathology, State Universi-
ties of Groningen and Leiden, The Netherlands. Six months after
unilateral nephrectomy (UN) of male Wistar rats 6.7% (0.0 to 25.5,
extreme values) of the glomeruli in the remaining left kidney showed
focal and segmental glomerular hyalinosis and sclerosis (FSGHS), after
1 year 27.0% (9.9 to 43.8). During this period a progressive proteinuria
developed in UN rats (99 42 mg/24 hr after 1 year, mean I SD) with
increased serum levels of cholesterol. In sham-operated (Sh) rats 0.5%
(0.0 to 2.0) of the glomeruli showed FSGHS at 6 months. After 1 year
the incidence was 1.1% (0.0 to 7.3). In contrast to Wistar rats male
PVG/C rats were much less susceptible to FSGHS: FSGHS was not
observed after 1 year in Sh or in UN PVG/C rats. No proteinuria or
serum alterations were noted. Body weight curves were identical to
those of Wistar rats. This difference in susceptibility to FSGHS
prompted us to study several renal morphologic and functional parame-
ters. Kidneys were digested in hydrochloric acid and glomeruli were
counted by light microscopy. Glomerular number per Wistar kidney (N
= 18) was 24951 1714, per PVG/C kidney (N = 20) 30487 1552 (P <
0.01). This difference cannot solely explain our findings since after UN
the remaining kidney of PGV/C rats contains less glomeruli than both
kidneys of Sh Wistar rats. Glomerular profiles were measured in plastic
sections 4 weeks after Sh or UN using a graphic tablet. Utilizing the
appropriate coefficients and equations the real glomerular diameters
were estimated from which glomerular volumina were calculated. After
UN the volume of Wistar glomeruli increased significantly (1.29 x 106
m3 — 1.71 x 106 tm3, P < 0.01), that of PVG/C glomeruli did not (1.22
X 10 tm3 —* 1.31 x 106 /sm3, NS). Whole kidney GFR was measured in
5 UN and 5 Sh rats of both strains by measuring the clearance of inulin
by the left kidney during 40 mm. Body weights, BP, and hematocrit
were identical. Mean GFR in Wistar Sh rats was 0.80 0.11 mI/mm, in
Wistar UN rats 1.45 0.17 mI/mm (P < 0.01). In PVG/C rats GFR was
not influenced by UN: Sh 1.01 0.21 mI/mm, UN 1.14 0.22 mllmin,
NS. Despite this difference in increase of GFR after UN the weight of
the remaining left kidney had increased significantly in both strains. In
conclusion, Wistar rats are more susceptible to FSGHS, have less
glomeruli, and react to UN with glomerular hypertrophy and increase of
GFR. In PVG/C rats no glomerular overload develops after UN. The
lack of adaptation of GFR and glomerular volume to UN in the PVGIC
strain may be related to an aberrant autoregulation mechanism.
Intrarenal sodium handling under extremes of sodium intake in normal
men.]. C. Roos, I. Delawi, H. A. Koomans, P. Boer, andE. J. Dorhout
Mews. Department of Nephrology and Hypertension, University Hospi-
tal Utrecht, Utrecht, The Netherlands. To investigate the hemodynam-
ic consequences and, in particular, the changes in intrarenal sodium
handling under extremes of sodium intake, eight healthy volunteers
were studied after three subsequent 4-day periods of increasing sodium
intake: 20, 200, and 1200 mEq/day in six of them; the remaining two
subjects who had a GFR less than 80 mI/mm received 900 mEq/day. All
subjects were in sodium balance the day prior to each study (mean
sodium excretion, respectively, 25 3, 189 14, and 1064 70 mEq/24
hr). Only the observed differences between low and extreme high-salt
intake are presented here. The mean increase in extracellular fluid
volume (ECFV, 82Br-distribution volume) amounted to 3.3 liters, with
a large variation in individual responses (range, 0 to 30% increase).
Overall, mean BP did not change. Plasma renin activity decreased by a
factor 19 (range, 7 to 38). No correlations were found between changes
in these three parameters. Mean GFR increased from 102 to 119 mI/mm
(P < 0.025). The mean fractional proximal sodium reabsorption
(fPRNa, calculated from maximal free-water clearance) decreased from
87 to 79% (P < 0.01). Fractional distal sodium reabsorption (fDRNa)
decreased from 97 to 76% (P < 0.01). Fractional lithium reabsorption
(fRLi), also a marker for proximal sodium reabsorption, decreased from
64 to 58% (NS) and was significantly correlated with IPRNa and not
with distal reabsorption. The percent changes in ECFV and FELl were
significantly correlated (r =
—0.85, P < 0.03), which indicates that the
less proximal sodium reabsorption is suppressed, the more volume
expansion results. In conclusion, fRLi appears to be an adequate
marker of proximal reabsorption. Healthy volunteers, on an extreme
high-sodium intake, excrete the sodium load with relatively small
increases in ECFV and minor changes in BP although the individual
responses showed a great variation. Those with less suppressed proxi-
mal sodium reabsorption showed the greatest volume expansion but
were able to excrete the same load by a larger increase in GFR and
suppression of fDRNa.
Renal vasodilatation and natriuresis by ACE-inhibitor enalaprilic acid
(MK-422). G. J. Navis, D. de Zeeuw, A. J. M. Donker, and P. E. de
Jong. Department of Nephrology, University Hospital Groningen,
Groningen, The Netherlands. The effects of single doses of MK-422
intravenously on renal hemodynamics (ERPF, GFR) and sodium excre-
tion were studied in six patients with moderate to severe essential
hypertension and a normal GFR. They adhered to a diet with fixed
amounts of sodium and potassium (both 100 mmoles/24 hr) and used no
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other antihypertensive medication for at least 14 days. The patients
were studied on a low dose of MK-422 (5 or 10 mg). Four of the six
patients were also studied on a high dose of MK-422 (20 or 40 mg).
ERPF and GFR were measured by continuous infusion of '311-Hippuran
and '251-iothalamate, respectively, using the formula .Throughout
the day I - or 2-hr urine samples were obtained for determination of
sodium, potassium, phosphate, and creatinine excretion. Plasma renin
activity (PRA) was measured before the MK-422 injection. One, three,
and five hours after MK-422 administered intravenously mean arterial
pressure had decreased by 6 2 (mean SEM) (P < 0.01), 7 3 (P <
0.01), and 8 2% (P < 0.01), respectively. ERPF (403 11 mI/mm)
increased with 7 3 (P < 0.01) and 16 3% (P < 0.01). GFR did not
change; thus, filtration fraction (0.25 0.01) decreased with 6 2, 9
4 (P < 0.05), and 10 2% (P < 0.01). With a low dose of MK-422, no
change in sodium excretion was found, whereas with a high dose an
increase was observed in all patients with a mean of 47 20% and 62
29% after 3 and 5 hr, respectively. Phosphate excretion and urinary
sodium/potassium ratio paralleled sodium excretion. Thus, effects on
both the proximal and the distal tubule contributed to the natriuresis. In
conclusion, MK-422 resulted in a decrease in BP and an increase in both
ERPF and sodium excretion. All were related to the PRA prior to
injection. Only the effect on sodium excretion seemed to be dose-
related. Since it is known that circulating ACE-activity is effectively
inhibited even at a low dose of MK-422, it could well be that the dose-
related natriuresis is partly the result of an inhibition of tissue (for
example, proximal tubule) ACE, whereas the effects on BP and ERPF
are related to the inhibition of ACE on the endothelial wall.
A-I converting enzyme inhibition induces deterioration in graft function
in patients with a transplant renal artery stenosis (TRAS). W. J. van Son,
F. van der Woude, A.J.M. Donker, M. J. H. Slooff, S. Meijer, S. J.
Hoorntje, A. M. Tegzess, and L. B. van der Slikke. University Hospital
Groningen, Groningen, The Netherlands. Hypertension has a high
prevalence in recipients of renal allografts and is still considered to be
one of the major clinical problems in these patients. The cause of
hypertension is believed to be multifactorial and includes sodium and
fluid retention, acute and chronic rejection, recurrence of original
disease, and transplant renal artery stenosis (TRAS). TRAS after renal
transplantation with an arterial lumen-narrowing of more than 80%
occurs in roughly 5% of the functioning grafts. The use of an angioten-
sion I converting enzyme inhibitor like captopril as an antihypertensive
drug in patients with hypertension after renal transplantation is no
longer an exception, and the antihypertension properties of this drug
are most impressive in these patients. Recently, an acute loss of renal
function after institution of captopril was reported in four patients with
TRAS. In the last 4 years we treated ten hypertensive patients with an
angiographically proven TRAS with captopril. Eight patients had one(stenosed) renal artery, two patients had two renal arteries, and one of
them stenosed. No machine preservation had been used. All patients
had a marked (reversible) deterioration in renal function after institution
of captopril, not attributable to a fall in systemic BP or dehydration. In
most patients there was no satisfying BP response; the only two
patients with a positive BP response were the two with a stenosis in one
out of two renal arteries. Interestingly, ssmTc DMSA scans before and
after institution of captopril in these two patients revealed a defect in
the poststenotic parenchyma after institution of the angiotensin I
converting enzyme inhibitor. In two patients the renal function could be
restored by cessation of the captopril treatment and institution of
minoxidil, with a positive BP response. Five patients underwent
surgical correction of the stenosis with on1y one failure. We believe that
the detrimental effects of captopril on renal function can be explained
by blocking of the intrarenal angiotensin II generation, which leads to
efferent vasodilation, and subsequently to a fall in hydrostatic filtration
pressure. In the situation of a stenosis in one out of two renal arteries,
captopril can be used to lower BP, although it might induce a functional
amputation of the poststenotic renal parenchyma ("two kidney, one
clip model"). Because of the good results of surgical correction in
patients with TRAS this mode of therapy should be considered.
The relative clearance of 99mTcDMSA: a new approach to measure
dysfunction of renal proximal tubuli. W. H. J. van Luyk, S. Mejer, A. J.
M. Donker, G. J. Ensing, and D. A. Piers. University Hospital,
Groningen, The Netherlands. Renal scintigraphy with °'Tc-DMSA
dimercaptosuccinate (DMSA) is a useful procedure to visualize the
renal cortex in patients with normal renal function. The urinary
excretion of mTcDMSA is so slow that the pyela and bladder cannot
be visualized. In patients with proximal tubulopathy, a low uptake in
the renal cortex and high urinary activity were found. To evaluate this
finding, mTcDMSA clearance studies were performed. Twenty pa-
tients with proximal tubular dysfunction and a control group of 18
patients with various nontubular renal diseases were investigated.
GFR, ranging 5 to 160 mI/mm/I .73 m2, and age, ranging from I to 68
years, were comparable in the two groups. Doses of 0.06 to 0.36 mg
99mTcDMSA were divided in a priming dose and a sustaining dose for
continuous infusion. Urine sampling started 1.5 to 2 hr after the priming
dose in periods of 3 x 20 mm (children) and 2)< 2 hours (adults). Blood
samples were drawn four to five times regularly during urine collection.
Serum levels of 99mTcDMSA were comparable in the two groups and
remained constant during the time of urine collection. GFR and
effective renal plasma flow (ERPF) were measured simultaneously by
means of 1251-sodium iothalamate and '311-hippurate. Tubular protein-
uria was established by elevated clearance of beta-2-microglobulin
(j32m) and lysozyme in relation to creatinine. thm was measured by a
radioimmunoassay and lysozyme by an electroimmunodiffusion tech-
nique. The relative clearance of S9mTcDMSA with respect to 1251..
sodiumiothalamate was larger than 14% in patients with proximal
tubulopathy and in contrast with control patients. A comparable
difference between the two groups was found in the relative clearance
of fl2m. Half of the patients with proximal tubulopathy showed an
elevated filtration fraction (GFRIERPF > 0.27), indicating a relatively
decreased secretion of hippurate. In patients with tubulopathy, relative
clearances of /32m were larger than relative clearances of S9mTcDMSA
and lysozyme. Considering the mechanisms responsible for renal
uptake and urinary excretion of "Tc-DMSA either glomerular filtra-
tion with tubular reabsorption or peritubular uptake and tubular secre-
tion are possible. In this respect the observation in a patient with
unilateral renal artery stenosis and hypertension is relevant. During
treatment with captopril, renal uptake of 99mTcDMSA and GFR of the
stenotic kidney were temporally absent and very low, respectively,
whereas blood flow as measured by tubular secretion of '311-hippurate
was preserved. In conclusion, an elevated relative clearance of s9mTc
DMSA represents proximal tubular dysfunction. The results in patients
with proximal tubulopathy are compatible with glomerular filtration and
subsequently impaired tubular reabsorption of the radiopharmaceutical.
